About: http://webisa.webdatacommons.org/220633481

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Sorafenib is an orally active multikinase inhibitor approved for the treatment of advanced hepatocellular carcinoma (HCC).
http://www.w3.org/ns/prov#wasQuotedFrom	chronicliverdisease.org